Scimitar Equity Research Issues Review on Physiometrix, Inc.
30 July 2004 - 12:05AM
PR Newswire (US)
Scimitar Equity Research Issues Review on Physiometrix, Inc.
BOSTON, July 29 /PRNewswire/ -- Scimitar Equity Research, Inc.
(Scimitar) today issued a review on Physiometrix, Inc.
(NASDAQ:PHYX). The analyst research review is available on
Scimitar's website; http://www.scimitarequity.com/. This review is
also available by calling Scimitar at (617) 236-6396. Scimitar
Equity Research, Inc. provides unbiased research and insightful
analysis of the health sciences industry for the institutional and
investment communities. Scimitar does not own any securities
related to the companies we provide analysis or develop research
products. We will not have investment banking relationships with
any company to maintain our independence and objectivity. Investors
are advised that this analysis and review is issued solely for
informational purposes and is not to be construed as an offer to
sell or the solicitation of an offer to buy. Scimitar was paid for
preparing this review. This analysis and review does not have
regard to the specific investment objectives, financial situation
and the information contained herein is based on sources that we
believe to be reliable but is not guaranteed by us as being
accurate and does not purport to be a complete statement or summary
of the available data. Any opinions expressed herein are statements
of our own judgment as of the date of publication and are subject
to change without notice. CONTACT: Scimitar Equity Research, Inc.
Henry W. McCusker Director of Research phone: (617) 236-6396 fax:
(617) 236-6397 e-mail: DATASOURCE: Scimitar Equity Research, Inc.
CONTACT: Henry W. McCusker, Director of Research of Scimitar Equity
Research, Inc., +1-617-236-6396, Web site:
http://www.scimitarequity.com/
Copyright
Physiometrix (NASDAQ:PHYX)
Historical Stock Chart
From May 2024 to Jun 2024
Physiometrix (NASDAQ:PHYX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Physiometrix (MM) (NASDAQ): 0 recent articles
More Physiometrix (MM) News Articles